Physician profile
Abha Dewan
NPI 1669421442
$957.50
in general payments reported to CMS, 2019-2025
16 companies · $161 in 2025
The $161 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $51.89 · 2021: $92.46 · 2022: $140 · 2023: $171 · 2024: $341 · 2025: $161.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $673.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $673.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $203.10 | 2021-2024 | Jornay Pm |
| Corium, LLC | $187.82 | 2022-2025 | Azstarys |
| Merck Sharp & Dohme LLC | $74.97 | 2020-2024 | Gardasil 9, Gardasil, Vaxneuvance |
| Alk-Abello, INC | $74.46 | 2025 | Neffy |
| Collegium Pharmaceutical, INC. | $64.69 | 2025 | Jornay Pm |
| Sanofi Pasteur INC. | $56.39 | 2020-2024 | |
| Hologic Sales and Service, LLC | $48.49 | 2023-2024 | Aptima, Affirm Prone Biopsy System |
| Astrazeneca Pharmaceuticals LP | $42.63 | 2021-2024 | |
| Kaleo, INC. | $42.11 | 2022 | |
| Sanofi-Aventis U.S. LLC | $37.54 | 2024 | |
| Tris Pharma INC | $26.50 | 2021-2022 | |
| Aytu Biopharma, INC. | $25.97 | 2021-2023 | |
| Biomarin Pharmaceutical INC. | $20.66 | 2024 | Voxzogo 1.2mg |
| Adlon Therapeutics L.P. | $18.40 | 2020 | |
| Glaxosmithkline, LLC. | $17.55 | 2024 | Bexsero |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cranial Technologies, INC | $16.22 | 2024 | Doc Band |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abha Dewan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.